Medical and Scientific Translation Across Canada Contact us Français

Home/Documents/Product Monograph Translation

Product Monograph Translation Services

Mediwords translates product monographs for pharmaceutical manufacturers, biotech companies and regulatory teams. Our primary specialization is English-to-Canadian-French translation of Health Canada product monographs, including Part I, Part II and Patient Medication Information. We also translate pharmaceutical product information into more than 30 languages for international markets, adapting terminology and document requirements to each destination.

Get a quote
  • Template headings kept
  • Approved terms
  • Double review
Pharmaceutical translator comparing the English and French versions of a product monograph

Trusted by healthcare and life sciences organizations

  • Dexcom logo, client of Mediwords
  • Canadian Cancer Society logo, client of Mediwords
  • Allianz logo, client of Mediwords
  • Sun Life logo, client of Mediwords
  • YMCA New Brunswick logo, client of Mediwords
  • Sinai Health logo, client of Mediwords

Specialized Translation of Pharmaceutical Product Monographs

A product monograph brings together the scientific, clinical and patient information used to describe a pharmaceutical product, including its indications, risks, dosage and conditions of use. Mediwords helps regulatory and pharmaceutical teams prepare accurate multilingual versions, with particular expertise in Canadian English–French product monographs and their required terminology and structure.

A product monograph is long, technical and regulated. It is written for three audiences at once: prescribers and pharmacists, scientists and reviewers, and patients. It is also read for years and updated many times, so every translation choice made today will be repeated in the next revision, on the label and in the package insert.

For Canadian submissions, our translators preserve Health Canada template headings, reuse approved terminology from earlier versions and check numbers, units and cross-references against the source. For other target markets, we follow the client’s approved references and the relevant local document format rather than applying Canadian headings automatically.

The Three Parts of a Canadian Product Monograph

For Health Canada submissions, the monograph has three parts, each with its own audience and translation requirements:

PartWhat it containsWhat the translation must get right
Part I: Health Professional InformationIndications, contraindications, the serious warnings and precautions box, dosage, overdosage, warnings, adverse reactions, interactions, clinical pharmacology and storagePrecise clinical terms, exact doses and the warning language used across Canadian monographs
Part II: Scientific InformationPharmaceutical information, clinical trials, microbiology and non-clinical toxicology, often with dense tablesEvery figure, unit, statistic and table reference aligned with the English
Patient Medication InformationWhat the drug is for, how to take it, side effects and what to do about them, in plain languagePlain French a patient understands, consistent with the label and the rest of the monograph

For Canadian French versions, we follow the official French headings in the applicable Health Canada master template and retain the corresponding section structure. Documents prepared for other countries may require a different format, terminology or content arrangement.

Product Monograph Headings in Canadian French

Health Canada’s master template uses numbered sections. The examples below illustrate the Canadian French terminology used in this specific regulatory context:

English headingFrench heading
1 Indications1 Indications
2 Contraindications2 Contre-indications
4 Dosage and Administration4 Posologie et administration
5 Overdosage5 Surdosage
6 Dosage Forms, Strengths, Composition and Packaging6 Formes posologiques, concentrations, composition et emballage
7 Warnings and Precautions7 Mises en garde et précautions
8 Adverse Reactions8 Effets indésirables
9 Drug Interactions9 Interactions médicamenteuses
11 Storage, Stability and Disposal11 Entreposage, stabilité et traitement
16 Non-Clinical Toxicology16 Toxicologie non clinique

Regulatory headings are not always literal translations. We follow the applicable Health Canada template and the approved product terminology, rather than substituting generic wording. Equivalent documents for other jurisdictions are handled according to their own conventions.

When You Need the French Product Monograph

Health Canada published a June 2025 notice on second-language product monograph filing. For Canadian submissions, the applicable requirements include:

  • A first language product monograph is the minimum at filing, and both languages are preferred. If a second language version was not provided during the review, it may be requested.
  • The final second-language product monograph is required after issuance of the notice of compliance (NOC), drug identification number (DIN) or no objection letter (NOL), as described in Health Canada’s notice.
  • Canadian product monographs are made available through Health Canada resources, including the Drug Product Database, for healthcare professionals and patients.

Regulatory teams often plan the Canadian French version early so that it can be finalized alongside the approved source. The Health Canada product monograph guidance and master template provide the relevant Canadian framework. Our regulatory translation team also handles the correspondence and supporting documents that accompany the submission.

What We Check in Every Monograph

The details reviewers and pharmacists notice first:

Drug Names

Non-proprietary names change in French, such as amoxicillin, which becomes amoxicilline. We use the French names found in Canadian references.

Doses and Numbers

We apply the target language’s number-formatting conventions while preserving doses, numerical values and units unless the client explicitly approves a change.

Adverse Reaction Tables

Long tables of adverse reactions keep the same order, the same frequencies and the same terms as the source.

Boxed Warnings

The serious warnings and precautions box keeps its exact wording in every version and on every related document.

Cross-References

References to sections, tables and figures still point to the right place after translation.

Consistency Over Time

We reuse approved terminology and previously translated text, while checking whether changes also affect related or otherwise unchanged passages.

Revisions, Labels and Related Documents

Most monograph work is not a first translation but an update: a new indication, a safety change, a new strength. We compare the revised source with the previous approved version, update the affected translation and review related passages for consistency. For Canadian projects, we can deliver Canadian French files with tracked changes for your regulatory review; the same version-control approach is available in other target languages.

A safety change in the monograph usually changes the label and the package insert too. Our page on drug label translation covers those documents, and we translate them from the same glossary so the warning reads the same way everywhere.

If you already have a French monograph and want an independent opinion before submission, our medical translation review service compares it with the English and tells you clearly what needs to change.

Monographs are one part of our pharmaceutical translation work, which also covers clinical, safety, manufacturing and promotional documents.

Patient Medication Information in Plain French

In the Canadian product monograph, the Patient Medication Information is written for patients and may also be supplied as a separate leaflet or other patient-facing material. It answers simple questions: what the medicine is for, how to take it, what to avoid, which side effects to watch for and what to do if they happen.

Plain language in English does not become plain language in French automatically. A literal translation of a short English sentence can produce a long, formal French one. Our translators write short sentences, use the words patients use and keep the side effect names consistent with Part I, so a pharmacist can move between both sections without confusion.

Canadian French and Other Languages

English-to-Canadian-French translation is our principal language combination for product monographs, particularly for the Canadian regulatory market. We also translate pharmaceutical product information into more than 30 languages, including Spanish, Portuguese, German, Italian, Arabic, Chinese and Japanese, depending on the project and intended market.

International projects may involve a summary of product characteristics (SmPC), a package leaflet or another market-specific product information document rather than a Canadian product monograph. We work from your approved source content, terminology and applicable templates, and flag differences in document structure for your regulatory team. Final local regulatory review and approval remain with the client and relevant authorities.

Who Sends Us Product Monographs

  • Brand-name manufacturers: new drug submissions, supplements and annual updates
  • Generic manufacturers: monographs aligned with the Canadian reference product
  • Biotech companies: a first product in Canada, often with a small regulatory team
  • Regulatory consultants: monographs prepared for several clients and products
  • Biologic and radiopharmaceutical sponsors: products covered by the same second language filing rules

How We Translate a Product Monograph

A structured process for full monographs, updates and multilingual product information:

  1. Reference collection. We gather the approved source monograph, previous target-language versions, label text, applicable templates and product glossaries.
  2. Translation. A pharmaceutical translator working into their native language translates in the required file format, following the applicable market-specific template.
  3. Revision. A second qualified linguist checks terminology, numbers, tables, cross-references and the clarity of patient-facing information.
  4. Quality check. The project manager checks headings, numbering, cross-references and formatting.
  5. Delivery. You receive an editable file in the requested language and, for updates when supported by the format, a tracked version for your review.

Our linguistic revision supports accuracy and consistency, but final approval of scientific content, labeling and regulatory submissions remains the responsibility of the sponsor and its regulatory team.

Product Monograph Translation FAQ

Do you translate the full product monograph?

Yes. We translate Part I, Part II and the Patient Medication Information, and keep the structure and headings of the Health Canada template.

Can you translate only the changes in a revised monograph?

Yes. We compare source versions, reuse approved translations and update affected passages, checking related content where necessary. Tracked changes can be provided when the file format supports them.

Do you use our existing French terminology?

Yes. We reuse terminology approved in your earlier monographs, labels and leaflets for each target language and market, unless you ask us to update it.

Who translates product monographs at Mediwords?

Pharmaceutical translators working into their native language, followed by independent linguistic revision. Canadian French remains our primary specialization.

Do you also translate the label and the package insert?

Yes. We translate labels, package inserts and patient leaflets from the same glossary as the monograph.

Can you review a French monograph prepared by someone else?

Yes. We check it against the approved source and identify linguistic errors, inconsistencies and terminology issues. Regulatory readiness and submission approval are determined by your regulatory team.

Do you translate monographs from French into English?

Yes. We translate French-language monographs into English and also handle other language combinations according to your destination market and document requirements.

Do you follow the current Health Canada template?

Yes, for Canadian product monographs. We follow the applicable Health Canada master template and approved headings. Other jurisdictions may require a different document structure.

Is the Patient Medication Information translated differently?

Yes. It is written for patients, so our translators keep the French plain and clear, while staying consistent with the clinical sections.

Can you translate product monographs into languages other than Canadian French?

Yes. Canadian French is our main specialization, but we also translate pharmaceutical product information into more than 30 languages. For international markets, we follow the relevant target-language terminology and the document structure supplied or approved by your regulatory team.

Get a Quote for Your Product Monograph

Send us the monograph, any previous translations, the target language or languages, the destination market and your submission date. We reply within one business day with a fixed price and a delivery date. You can also write to us at info@mediwords.ca.